On the combined impact of COVID, RSV and influenza this winter, Peter Graven, Ph.D., says taking proven precautions like wearing a face mask in crowded public spaces and staying home when you’re unwell can help dull the current surge, adding: “I know people are kind of tearing of hearing some of that stuff. We’re not saying people need to change your life forever. Right now, for the next some number of weeks, we’re not in a great spot.”

Honora Englander, M.D., Ximena Levander, M.D., and Jessica Gregg, M.D., Ph.D., argue for a new approach to addiction treatment, calling for programmatic and policy changes that, they argue, could “begin to address disparities and inequities, and save lives.”

Yali Jia, Ph.D., is receiving a Research to Prevent Blindness grant to develop a new imaging platform to measure neurovascular changes associated with age-related macular degeneration.

In a story exploring how patients experiencing long COVID often feel isolated, Jordan Anderson, D.O., says even patients who live with loved ones can feel alone if their family members don’t understand the condition or take it seriously, and that patients can find comfort by participating in support groups.

Peter Graven, Ph.D., is quoted in an op-ed by ECONorthwest policy adviser John Tapogna that thanks Oregon Gov. Kate Brown for her service. While discussing the tough decisions Brown made during the pandemic, Graven says: “It was an ongoing cost-benefit analysis of everything society values the most—life, livelihoods and human connection.”

Coverage of DoveLewis Portland Area Canine Therapy Teams comforting holiday travelers at Portland International Airport notes the dogs also visit OHSU.

Coverage of various Oregon reports related to respiratory illness prevalence notes OHSU’s Dec. 16 forecast predicts COVID-19 hospitalizations will continue to fall and begin to plateau in February or March.

On the COVID, flu, RSV issue: Dana Braner, M.D. as describing the confluence of diseases as the “greatest threat to children’s health in our state that we have seen in the last 30 years.”

The OHSU Knight Cancer Institute is the only cancer center in the Pacific Northwest selected to participate in a National Cancer Institute-led consortium to accelerate cancer drug discovery. Sanjay Malhotra, Ph.D., says: “We want to attract scientists at OHSU and beyond who have clever ideas for new and improved cancer therapies, and provide them the expertise and infrastructure for translating discoveries from the lab to the clinic.”

The OHSU Knight Cancer Institute is the only cancer center in the Pacific Northwest selected to participate in a National Cancer Institute-led consortium to accelerate cancer drug discovery. Sanjay Malhotra, Ph.D., says: “We want to attract scientists at OHSU and beyond who have clever ideas for new and improved cancer therapies, and provide them the expertise and infrastructure for translating discoveries from the lab to the clinic.”